References
- Veronesi U. The sentinel node and breast cancer. Br J Surg 1999; 86: 1–2.
- Nieweg OE, Jansen L, Valdes Olmos RA, et al. Lymphatic mapping and sentinel lymph node biopsy in breast cancer. Eur J Nucl Med 1999; 26 (Suppl 4): S11–6.
- Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992; 127: 392–9.
- 011ila DW, Brennan MB, Giuliano AE. The role of intraoper-ative lymphatic mapping and sentinel lymphadenectomy in the management of patients with breast cancer. Adv Surg 1999; 32: 349–64.
- Glass EC, Essner R, Giuliano AE. Sentinel node localization in breast cancer. Semin Nucl Med 1999; 29: 57–68.
- Hill AD, Tran KN, Akhurst T, et al. Lessons learned from 500 cases of lymphatic mapping for breast cancer. Ann Surg 1999; 229: 528–35.
- Noguchi M, Tsugawa K, Bando E, et al. Sentinel lymphadenectomy in breast cancer: identification of sentinel lymph node and detection of metastases. Breast Cancer Res Treat 1999; 53: 97–104.
- Chu KU, Turner RR, Hansen NM, Brennan MB, Bilchik A, Giuliano AE. Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissec-tion? Ann Surg 1999; 229: 536–41.
- Turner RR, 011ila DW, Stern S, Giuliano AE. Optimal histopathologic examination of the sentinel lymph node for breast carcinoma staging. Am J Surg Pathol 1999; 23: 263–7.
- Dowlatshahi K, Fan M, Snider HC, Habib FA. Lymph node micrometastases from breast carcinoma: reviewing the dilemma. Cancer 1997; 80: 1188–97.
- van Diest PJ, Peterse HL, Borgstein PJ, Hoekstra O, Meijer CJ. Pathological investigation of sentinel lymph nodes. Eur J Nucl Med 1999; 26 (Suppl 4): S43–9.
- Schreiber RH, Pendas S, Ku NN, et al. Microstaging of breast cancer patients using cytokeratin staining of the sen-tinel lymph node. Ann Surg Oncol 1999; 6: 95–101.
- Pendas S, Dauway E, Cox CE, et al. Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients. Am Surg 1999; 65: 500–5.
- Viale G, Bosari S, Mazzarol G, et al. Intraoperative examina-tion of axillary sentinel lymph nodes in breast carcinoma patients. Cancer 1999; 85: 2433–8.
- McGuckin MA, Cummings MC, Walsh MD, Hohn BG, Bennett IC, Wright RG. Occult axillary node metastases in breast cancer: their detection and prognostic significance. Br J Cancer 1996; 73: 88–95.
- Fisher CJ, Hill S, Millis RR. Benign lymph node inclusions mimicking metastatic carcinoma. J Clin Pathol 1994; 47: 245–7.
- Gould VE, Bloom KJ, Franke WW, Warren WH, Moll R. Increased numbers of cytokeratin-positive reticulum cells (CIRC) in reactive, inflammatory and neoplastic lymphadenopathies; hyperplasia or induced expression? Vir-chows Archiv 1995; 425: 617–29.
- Cody HS, Hill AD, Tran KN, Brennan MF, Borgen PI. Credentialing for breast lymphatic mapping: how many cases are enough? Ann Surg 1999; 229: 723–6.
- Veronesi U, Paganelli G, Viale G, et al. Sentinel lymph node biopsy and axillary dissection in breast: results in a large series. J Natl Cancer Inst 1999; 91: 368–73.
- Cox CE, Bass SS, Ku NN, et al. Sentinel lymphadenectomy: a safe answer to less axillary surgery? Recent Results Cancer Res 1998; 152: 170–9.